Oncology Market Research Reports, Oncology Industry Analysis Oncology Market Size, Share, Growth & Forecast ResearchMoz

Home
Oncology

Browse All Oncology Market Research Reports

List of reports from Oncology

Displaying 1 to 29 (of 29 records)

Pages: « Last 1

Neogenix Oncology, Inc. - Product Pipeline Analysis, 2013 Update May 2013 \| By - GlobalData Neogenix Oncology, Inc. - Product Pipeline Analysis, 2013 Update Summary Neogenix Oncology, Inc. (NOI) is a clinical stage biotechnology company. The company develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy...	$750
Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players Apr 2013 \| By - GBI Research Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players’, which provides in-depth analysis of the...	$3500
Light Sciences Oncology, Inc. Product Pipeline Review 2012 Dec 2012 \| By - Global Markets Direct Light Sciences Oncology, Inc. Product Pipeline Review 2012 Summary Global Market Directs pharmaceuticals report, Light Sciences Oncology, Inc. - Product Pipeline Review - 2012 provides data on the Light Sciences Oncology, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and...	$1500
Clovis Oncology, Inc. Product Pipeline Review 2012 Dec 2012 \| By - Global Markets Direct Clovis Oncology, Inc. Product Pipeline Review 2012 Summary Global Market Directs pharmaceuticals report, Clovis Oncology, Inc. Product Pipeline Review 2012 provides data on the Clovis Oncology, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and...	$1500
Civatech Oncology Inc. - Product Pipeline Analysis Dec 2012 \| By - GlobalData Summary Civatech Oncology Inc. (Civatech) is a medical device company. It focuses on the development of novel polymer based devices for the treatment of cancer using localized, low-dose-rate radiation. The company's product portfolio consists of CivaString and CivaSheet. CivaString, a linear brachytherapy device that contains palladium-103, delivers improved homogeneous radiation dose over...	$750
Clovis Oncology, Inc. - Product Pipeline Review - 2012 Dec 2012 \| By - Global Markets Direct Clovis Oncology, Inc. Product Pipeline Review 2012 Summary Global Market Directs pharmaceuticals report, Clovis Oncology, Inc. Product Pipeline Review 2012 provides data on the Clovis Oncology, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and...	$1500
Neogenix Oncology, Inc. Product Pipeline Review 2012 Nov 2012 \| By - Global Markets Direct Neogenix Oncology, Inc. Product Pipeline Review 2012 Summary Global Market Directs pharmaceuticals report, Neogenix Oncology, Inc. Product Pipeline Review 2012 provides data on the Neogenix Oncology, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and...	$1500
ZIOPHARM Oncology, Inc. - Product Pipeline Review - 2012 Aug 2012 \| By - Global Markets Direct ZIOPHARM Oncology, Inc. Product Pipeline Review 2012 Global Markets Directs pharmaceuticals report, ZIOPHARM Oncology, Inc. Product Pipeline Review 2012 provides data on the ZIOPHARM Oncology, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant...	$1500
Global Radiation Oncology Market 2011-2015 Aug 2012 \| By - Technavio TechNavio's analysts forecast the Global Radiation Oncology market to grow at a CAGR of 7.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Radiation Oncology market has also been witnessing the trend of increasing adoption of image-guided radiation therapy. However, the availability of...	$1500
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities Jul 2012 \| By - GBI Research Pharmaceutical Pricing and Reimbursement in Oncology Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities Summary GBI Research, leading business intelligence provider, has released its latest research report, entitled “Pharmaceutical Pricing and Reimbursement in Oncology Payer Pressure to Justify Premium Pricing of Novel...	$3500
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline Jul 2012 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research, Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline which provides insights into the global oncology pipeline. The report is built using data and information sourced from proprietary databases, primary and secondary...	$3500
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications Jun 2012 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research, Translational Regenerative Medicine Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications, which provides insights into the global regenerative medicine therapeutics market. The report provides an in-depth analysis of regenerative medicine...	$3500
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules Apr 2012 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules, which provides insights into the Oncology orphan disease therapeutics market until 2018. The report is built using...	$3500
Oncology Pharmaceuticals Market in India 2012 Apr 2012 \| By - Netscribes (India) Pvt. Ltd. Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and...	$795
Oncology Partnering Terms and Agreements Feb 2012 \| By - Current Partnering The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter oncology partnering deals. The majority of deals are discovery or development stage...	$2995
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market Dec 2011 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market which provides insights about monoclonal antibodies sales forecasts until 2017. Monoclonal antibodies markets in the key geographies of the US,...	$3500
Neogenix Oncology, Inc. - Product Pipeline Analysis Nov 2011 \| By - GlobalData Neogenix Oncology, Inc. - Product Pipeline Analysis Summary Neogenix Oncology, Inc. (Neogenix) is a biotechnology company that is engaged in the development of diagnostic and therapeutic products for the treatment of various types of cancers like lung, pancreatic, cervical, prostate and colorectal cancer. The products developed by the company include cancer vaccines, diagnostic monoclonal...	$750
Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology Nov 2011 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research, Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology. It gives a robust idea about the patient recruitment status by geography, by Sponsor Company and by year for all the major orphan diseases in CNS and oncology. The report...	$3500
Oncology Pharmaceuticals Market in India 2011 Aug 2011 \| By - Netscribes (India) Pvt. Ltd. Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in the global market. Since cancer is the second largest cause of death in the country, the Indian market is characterized by a huge demand for cancer drugs. It is a highly fragmented market with a large number of foreign and domestic...	$795
Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development Jul 2011 \| By - GBI Research GBI Research, a leading business intelligence provider, has released its latest research Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development, which provides insights into the unmet needs targeted by late stage pipeline molecules across major therapy areas. The report examines the safety,...	$3500
The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting - Post Conference Review and Analysis Jun 2011 \| By - GlobalData GlobalData, the industry analysis specialist, has released its new conference alerts, “The 2011 ASCO (American Society of Clinical Oncology) Annual Meeting - Post Conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques. Scope The report provides complete coverage...	$1000
Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology May 2011 \| By - GBI Research GBI Researchs report, Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology, provides in-depth analysis of innovations in protein kinase therapies in the current pharmaceutical market. The report analyzes the protein kinase pipelines of pharmaceutical companies by indication, and also according to the...	$3500
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost May 2011 \| By - GBI Research GBI Research has released its research, Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost, which provides insights into recruitment strategies, challenges and solutions for on-time recruitment in oncology trials. The report also examines case studies to illustrate enhanced...	$3500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology Mar 2011 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Endpoints in Oncology Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology, which essentially provides insights into clinical trial endpoints in oncology. The report details the endpoints and application of endpoints in oncological clinical...	$3500
Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market Jan 2011 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research, Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market, which provides insights into oncology sales and price forecasts until 2017. The report also examines the Chinese oncology treatment usage patterns. In...	$3500
Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential Dec 2010 \| By - GBI Research GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential”, which provides insights into oncology sales and price forecasts until 2017. The report also examines the Indian oncology treatment usage patterns. In...	$3500
Oncology Pipeline Database: 1-Year Subscription May 2010 \| By - La Merie Publishing Oncology Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive. Data sets of interest...	$2316
Global Radiation Oncology Market 2009-2013 Feb 2010 \| By - Technavio Radiation Oncology is the therapeutic treatment that uses high energy ionizing radiation to treat cancers. The increasing prevalence of cancer cases in both developed as well as developing countries is a major concern in the healthcare industry. Cancer care programs employing radiation treatment is significantly improving the survival rates of many cancer types: head, neck , lung,...	$1500
Oncology Pipeline Database: 6-Month Subscription Feb 2010 \| By - La Merie Publishing Oncology Pipeline Database: 6-Month Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive. Data sets of interest...	$1544